Source: International Congress 2018 – Mechanisms of respiratory infection
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. Bodier-Montagutelli (Tours, France), J. Pardessus (Tours, France), E. Dalloneau (Tours, France), C. Fevre (Romainville, France), G. L'Hostis (Romainville, France), E. Morello (Tours, France), J. Gabard (Romainville, France), S. Le Guellec (Saint Etienne, France), R. Respaud (Tours, France), L. Vecellio (Tours, France), N. Heuzé-Vourc'H (Tours, France). Inhaled phage therapy for the treatment of acute Pseudomonas aeruginosa lung infections. 2649

Member's Comments

No comment yet.

Related content which might interest you: Inhaled corticosteroid use and its association with Pseudomonas aeruginosa infection in COPD Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021 Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73 Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Efficacy of Pseudomonas aeruginosa eradication regimens in bronchiectasis Source: Eur Respir J , 49 (4)  1600851; DOI: 10.1183/13993003.00851-2016 Year: 2017 Highly concentrated aerosolized tobramycin in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection Source: Eur Respir J 2005; 26: Suppl. 49, 620s Year: 2005 Pseudomonas aeruginosa and antibiotic resistance in acute exacerbations of COPD (AECOPD) Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa Year: 2009 Long term treatment with azithromycin in chronic respiratory infections with pseudomonas aeruginosa Source: Eur Respir J 2006; 28: Suppl. 50, 558s Year: 2006 The clinical impact of nebulised antibiotics in adults with bronchiectasis and chronic pseudomonas aeruginosa Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020 The effect of erythromycin on the chronic lower airway infection by pseudomonas aeruginosa Source: Eur Respir J 2004; 24: Suppl. 48, 640s Year: 2004 Pulmonary infections with pseudomonas aeruginosa Source: Eur Respir J 2004; 24: Suppl. 48, 642s Year: 2004 Novel Pseudomonas aeruginosa scoring system to guide empiric anti-pseudomonal therapy in COPD patients with community-acquired pneumònia Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections Year: 2020 Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis}, Source: Eur Respir J 2012; 40: 1014-1023 Year: 2012 Pseudomonas aeruginosa drug susceptibility in patients hospitalized with COPD exacerbation and bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 541s Year: 2001 Azithromycin in chronic respiratory infections with pseudomonas aeruginosa in patients without cystic fibrosis Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008 The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis Source: Eur Respir J 2006; 28: 974-979 Year: 2006 Immunomodulatory properties of macrolide antibiotics in the treatment of bronchial sepsis involving P. aeruginosa Source: Eur Respir J 2004; 24: Suppl. 48, 639s Year: 2004 PcrV antibody prophylaxis in combination with antibiotic therapy reduces lung injury and improves survival in pseudomonas aeruginosa infected mice Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Inhaled antibiotics, pneumonia and bacterial resistance in the ICU Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018 The efficacy of early eradication therapy in prevention of chronic pseudomonas aeruginosa infection in cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 486s Year: 2006 Comparison between two protocols of preventing treatment of chronic Pseudomonas aeruginosa (Pa) infection Source: Eur Respir J 2005; 26: Suppl. 49, 620s Year: 2005